Diversification Versus Focus Dilemma Spotlights OTC Business Value

As the pharmaceutical industry's revenue hole deepens, CEOs face two main routes: banking on innovation, or diversifying through generics, OTC and other non-core businesses

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet